Scilit logo
  • Rankings
  • Search Publications
    Cited-by Search
  • Sources
  • Publishers
  • Scholars
    Top Cited Scholars
  • Organizations
  • Scilit
    About Us
    Advisory Board
    Data Sources
    Career
    Support / Contact
    User Guide
    Publisher User
    Search Function
    Rankings Function
    API Resource
    Scilit Knowledge
    Metrics
    Scilit Recognitions
    Publications Classification
    Media
    News
    Blog
Register
  1. Home
  2. Publications
  3. Supplementary Table S2 from Methylation-Based ctDNA Tumor Fraction Changes Predict Long-Term Clinical Benefit From Immune Checkpoint Inhibitors in RADIOHEAD, a Real-World Pan-Cancer Study
  1. Home
  2. Publications
  3. Supplementary Table S2 from Methylation-Based ctDNA Tumor Fraction Changes Predict Long-Term Clinical Benefit From Immune Checkpoint Inhibitors in RADIOHEAD, a Real-World Pan-Cancer Study

Supplementary Table S2 from Methylation-Based ctDNA Tumor Fraction Changes Predict Long-Term Clinical Benefit From Immune Checkpoint Inhibitors in RADIOHEAD, a Real-World Pan-Cancer Study

Authors:
  • SLSamantha I. Liang
    Samantha I. Liang
  • ZQZoe Quandt
    Zoe Quandt
  • SWSara Wienke
    Sara Wienke
  • JWJing Wang
    Jing Wang
  • SGSean Gordon
    Sean Gordon
  • RBReagan M. Barnett
    Reagan M. Barnett
  • JMJude Masannat
    Jude Masannat
  • KCKyle Chang
    Kyle Chang
  • CECarin R. Espenschied
    Carin R. Espenschied
  • KQKatie J. Quinn
    Katie J. Quinn
  • KBKimberly C. Banks
    Kimberly C. Banks
  • EYEnjun Yang
    Enjun Yang

Open Access
Publisher website
Google Scholar
  • 20 August 2025
    • other
    • Published by American Association for Cancer Research (AACR)
    • DOI:10.1158/2767-9764.29948078
Abstract
Methylation TF Results by Timepoint
Keywords
  • SUPPLEMENTARY TABLE
  • TUMOR FRACTION
  • CLINICAL BENEFIT
  • IMMUNE CHECKPOINT
  • CHECKPOINT INHIBITORS
  • STUDY METHYLATION
  • CTDNA TUMOR
  • PREDICT LONG-TERM
  • LONG-TERM CLINICAL
  • PAN-CANCER STUDY
Scilit logo

Have questions? Email us at support@scilit.com

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.

MDPI initiatives

  • MDPI Journals
  • MDPI Books
  • Sciforum
  • Proceedings Series
  • Preprints.org
  • SciProfiles
  • Encyclopedia
  • JAMS

Legal

  • Privacy
  • Terms
  • About
  • Contact
  • Disclaimer

Follow us

  • facebook icon
  • x icon
  • linkedin icon

Join us

  • Career

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.